BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy2129
(498 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3QHR|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 261
Score = 246 bits (629), Expect = 2e-65, Method: Compositional matrix adjust.
Identities = 132/297 (44%), Positives = 183/297 (61%), Gaps = 54/297 (18%)
Query: 198 DYRDDIYQYLLKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAI 257
DY++DI+ YL + E + +PK YM++Q DI + MR++LVDW
Sbjct: 6 DYQEDIHTYLREMEVKCKPKVGYMKRQPDITNSMRAILVDW------------------- 46
Query: 258 NYVDRFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSV 317
++EV EEYK+ NETLHLA+NY+DRFLS MSV
Sbjct: 47 -----------------------------LVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 77
Query: 318 VRSKLQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNFDLNI 377
+R KLQL+GT A+ +ASK+EEIYPPEV EFVYITDDTY+KKQ+L+ME L+LKVL FDL
Sbjct: 78 LRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYSKKQVLRMEHLVLKVLAFDLAA 137
Query: 378 PTVHSFICHITVSGHLDQS---VLYLAQYLSELALVSGDPFLQFLPSLIACSAIALARYC 434
PTV+ F+ + HL + V LA +L EL+L+ DP+L++LPSLIA +A LA Y
Sbjct: 138 PTVNQFLTQYFL--HLQPANCKVESLAMFLGELSLIDADPYLKYLPSLIAGAAFHLALYT 195
Query: 435 LDYKEAWPSSLADITGHSLDSLTECVKCLHEVHRKGEAASQKAAYNKYKLNLWKNVS 491
+ ++WP SLA TG++L+SL C+ LH+ + K +Q++ KYK + + +VS
Sbjct: 196 VT-GQSWPESLAQQTGYTLESLKPCLVDLHQTYLKAPQHAQQSIREKYKHSKYHSVS 251
>pdb|4II5|B Chain B, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|D Chain D, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 258
Score = 246 bits (629), Expect = 2e-65, Method: Compositional matrix adjust.
Identities = 132/297 (44%), Positives = 183/297 (61%), Gaps = 54/297 (18%)
Query: 198 DYRDDIYQYLLKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAI 257
DY++DI+ YL + E + +PK YM++Q DI + MR++LVDW
Sbjct: 3 DYQEDIHTYLREMEVKCKPKVGYMKRQPDITNSMRAILVDW------------------- 43
Query: 258 NYVDRFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSV 317
++EV EEYK+ NETLHLA+NY+DRFLS MSV
Sbjct: 44 -----------------------------LVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 74
Query: 318 VRSKLQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNFDLNI 377
+R KLQL+GT A+ +ASK+EEIYPPEV EFVYITDDTY+KKQ+L+ME L+LKVL FDL
Sbjct: 75 LRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYSKKQVLRMEHLVLKVLAFDLAA 134
Query: 378 PTVHSFICHITVSGHLDQS---VLYLAQYLSELALVSGDPFLQFLPSLIACSAIALARYC 434
PTV+ F+ + HL + V LA +L EL+L+ DP+L++LPSLIA +A LA Y
Sbjct: 135 PTVNQFLTQYFL--HLQPANCKVESLAMFLGELSLIDADPYLKYLPSLIAGAAFHLALYT 192
Query: 435 LDYKEAWPSSLADITGHSLDSLTECVKCLHEVHRKGEAASQKAAYNKYKLNLWKNVS 491
+ ++WP SLA TG++L+SL C+ LH+ + K +Q++ KYK + + +VS
Sbjct: 193 VT-GQSWPESLAQQTGYTLESLKPCLVDLHQTYLKAPQHAQQSIREKYKHSKYHSVS 248
>pdb|4I3Z|B Chain B, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|D Chain D, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 257
Score = 246 bits (629), Expect = 2e-65, Method: Compositional matrix adjust.
Identities = 132/297 (44%), Positives = 183/297 (61%), Gaps = 54/297 (18%)
Query: 198 DYRDDIYQYLLKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAI 257
DY++DI+ YL + E + +PK YM++Q DI + MR++LVDW
Sbjct: 3 DYQEDIHTYLREMEVKCKPKVGYMKRQPDITNSMRAILVDW------------------- 43
Query: 258 NYVDRFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSV 317
++EV EEYK+ NETLHLA+NY+DRFLS MSV
Sbjct: 44 -----------------------------LVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 74
Query: 318 VRSKLQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNFDLNI 377
+R KLQL+GT A+ +ASK+EEIYPPEV EFVYITDDTY+KKQ+L+ME L+LKVL FDL
Sbjct: 75 LRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYSKKQVLRMEHLVLKVLAFDLAA 134
Query: 378 PTVHSFICHITVSGHLDQS---VLYLAQYLSELALVSGDPFLQFLPSLIACSAIALARYC 434
PTV+ F+ + HL + V LA +L EL+L+ DP+L++LPSLIA +A LA Y
Sbjct: 135 PTVNQFLTQYFL--HLQPANCKVESLAMFLGELSLIDADPYLKYLPSLIAGAAFHLALYT 192
Query: 435 LDYKEAWPSSLADITGHSLDSLTECVKCLHEVHRKGEAASQKAAYNKYKLNLWKNVS 491
+ ++WP SLA TG++L+SL C+ LH+ + K +Q++ KYK + + +VS
Sbjct: 193 VT-GQSWPESLAQQTGYTLESLKPCLVDLHQTYLKAPQHAQQSIREKYKHSKYHSVS 248
>pdb|3DDQ|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
Length = 269
Score = 241 bits (615), Expect = 7e-64, Method: Compositional matrix adjust.
Identities = 127/295 (43%), Positives = 178/295 (60%), Gaps = 50/295 (16%)
Query: 198 DYRDDIYQYLLKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAI 257
DY +DI+ YL + E + +PK YM+KQ DI + MR++LVDW
Sbjct: 7 DYHEDIHTYLREMEVKCKPKVGYMKKQPDITNSMRAILVDW------------------- 47
Query: 258 NYVDRFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSV 317
++EV EEYK+ NETLHLA+NY+DRFLS MSV
Sbjct: 48 -----------------------------LVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 78
Query: 318 VRSKLQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNFDLNI 377
+R KLQL+GT A+ +ASK+EEIYPPEV EFVYITDDTYTKKQ+L+ME L+LKVL FDL
Sbjct: 79 LRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLAFDLAA 138
Query: 378 PTVHSFICHITVSGH-LDQSVLYLAQYLSELALVSGDPFLQFLPSLIACSAIALARYCLD 436
PT++ F+ + + V LA +L EL+L+ DP+L++LPS+IA +A LA Y +
Sbjct: 139 PTINQFLTQYFLHQQPANCKVESLAMFLGELSLIDADPYLKYLPSVIAAAAFHLALYTVT 198
Query: 437 YKEAWPSSLADITGHSLDSLTECVKCLHEVHRKGEAASQKAAYNKYKLNLWKNVS 491
++WP SL TG++L++L C+ LH+ + + +Q++ KYK + + VS
Sbjct: 199 -GQSWPESLVQKTGYTLETLKPCLLDLHQTYLRAPQHAQQSIREKYKNSKYHGVS 252
>pdb|3DDP|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
Length = 268
Score = 241 bits (615), Expect = 7e-64, Method: Compositional matrix adjust.
Identities = 127/295 (43%), Positives = 178/295 (60%), Gaps = 50/295 (16%)
Query: 198 DYRDDIYQYLLKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAI 257
DY +DI+ YL + E + +PK YM+KQ DI + MR++LVDW
Sbjct: 7 DYHEDIHTYLREMEVKCKPKVGYMKKQPDITNSMRAILVDW------------------- 47
Query: 258 NYVDRFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSV 317
++EV EEYK+ NETLHLA+NY+DRFLS MSV
Sbjct: 48 -----------------------------LVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 78
Query: 318 VRSKLQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNFDLNI 377
+R KLQL+GT A+ +ASK+EEIYPPEV EFVYITDDTYTKKQ+L+ME L+LKVL FDL
Sbjct: 79 LRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLAFDLAA 138
Query: 378 PTVHSFICHITVSGH-LDQSVLYLAQYLSELALVSGDPFLQFLPSLIACSAIALARYCLD 436
PT++ F+ + + V LA +L EL+L+ DP+L++LPS+IA +A LA Y +
Sbjct: 139 PTINQFLTQYFLHQQPANCKVESLAMFLGELSLIDADPYLKYLPSVIAAAAFHLALYTVT 198
Query: 437 YKEAWPSSLADITGHSLDSLTECVKCLHEVHRKGEAASQKAAYNKYKLNLWKNVS 491
++WP SL TG++L++L C+ LH+ + + +Q++ KYK + + VS
Sbjct: 199 -GQSWPESLVQKTGYTLETLKPCLLDLHQTYLRAPQHAQQSIREKYKNSKYHGVS 252
>pdb|3BHT|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|B Chain B, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|D Chain D, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|B Chain B, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|D Chain D, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
Length = 262
Score = 241 bits (615), Expect = 7e-64, Method: Compositional matrix adjust.
Identities = 127/295 (43%), Positives = 178/295 (60%), Gaps = 50/295 (16%)
Query: 198 DYRDDIYQYLLKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAI 257
DY +DI+ YL + E + +PK YM+KQ DI + MR++LVDW
Sbjct: 7 DYHEDIHTYLREMEVKCKPKVGYMKKQPDITNSMRAILVDW------------------- 47
Query: 258 NYVDRFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSV 317
++EV EEYK+ NETLHLA+NY+DRFLS MSV
Sbjct: 48 -----------------------------LVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 78
Query: 318 VRSKLQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNFDLNI 377
+R KLQL+GT A+ +ASK+EEIYPPEV EFVYITDDTYTKKQ+L+ME L+LKVL FDL
Sbjct: 79 LRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLAFDLAA 138
Query: 378 PTVHSFICHITVSGH-LDQSVLYLAQYLSELALVSGDPFLQFLPSLIACSAIALARYCLD 436
PT++ F+ + + V LA +L EL+L+ DP+L++LPS+IA +A LA Y +
Sbjct: 139 PTINQFLTQYFLHQQPANCKVESLAMFLGELSLIDADPYLKYLPSVIAAAAFHLALYTVT 198
Query: 437 YKEAWPSSLADITGHSLDSLTECVKCLHEVHRKGEAASQKAAYNKYKLNLWKNVS 491
++WP SL TG++L++L C+ LH+ + + +Q++ KYK + + VS
Sbjct: 199 -GQSWPESLVQKTGYTLETLKPCLLDLHQTYLRAPQHAQQSIREKYKNSKYHGVS 252
>pdb|3DOG|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 264
Score = 241 bits (615), Expect = 7e-64, Method: Compositional matrix adjust.
Identities = 127/295 (43%), Positives = 178/295 (60%), Gaps = 50/295 (16%)
Query: 198 DYRDDIYQYLLKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAI 257
DY +DI+ YL + E + +PK YM+KQ DI + MR++LVDW
Sbjct: 7 DYHEDIHTYLREMEVKCKPKVGYMKKQPDITNSMRAILVDW------------------- 47
Query: 258 NYVDRFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSV 317
++EV EEYK+ NETLHLA+NY+DRFLS MSV
Sbjct: 48 -----------------------------LVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 78
Query: 318 VRSKLQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNFDLNI 377
+R KLQL+GT A+ +ASK+EEIYPPEV EFVYITDDTYTKKQ+L+ME L+LKVL FDL
Sbjct: 79 LRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLAFDLAA 138
Query: 378 PTVHSFICHITVSGH-LDQSVLYLAQYLSELALVSGDPFLQFLPSLIACSAIALARYCLD 436
PT++ F+ + + V LA +L EL+L+ DP+L++LPS+IA +A LA Y +
Sbjct: 139 PTINQFLTQYFLHQQPANCKVESLAMFLGELSLIDADPYLKYLPSVIAAAAFHLALYTVT 198
Query: 437 YKEAWPSSLADITGHSLDSLTECVKCLHEVHRKGEAASQKAAYNKYKLNLWKNVS 491
++WP SL TG++L++L C+ LH+ + + +Q++ KYK + + VS
Sbjct: 199 -GQSWPESLVQKTGYTLETLKPCLLDLHQTYLRAPQHAQQSIREKYKNSKYHGVS 252
>pdb|2G9X|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
Length = 262
Score = 241 bits (615), Expect = 8e-64, Method: Compositional matrix adjust.
Identities = 127/295 (43%), Positives = 178/295 (60%), Gaps = 50/295 (16%)
Query: 198 DYRDDIYQYLLKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAI 257
DY +DI+ YL + E + +PK YM+KQ DI + MR++LVDW
Sbjct: 7 DYHEDIHTYLREMEVKCKPKVGYMKKQPDITNSMRAILVDW------------------- 47
Query: 258 NYVDRFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSV 317
++EV EEYK+ NETLHLA+NY+DRFLS MSV
Sbjct: 48 -----------------------------LVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 78
Query: 318 VRSKLQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNFDLNI 377
+R KLQL+GT A+ +ASK+EEIYPPEV EFVYITDDTYTKKQ+L+ME L+LKVL FDL
Sbjct: 79 LRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLAFDLAA 138
Query: 378 PTVHSFICHITVSGH-LDQSVLYLAQYLSELALVSGDPFLQFLPSLIACSAIALARYCLD 436
PT++ F+ + + V LA +L EL+L+ DP+L++LPS+IA +A LA Y +
Sbjct: 139 PTINQFLTQYFLHQQPANCKVESLAMFLGELSLIDADPYLKYLPSVIAAAAFHLALYTVT 198
Query: 437 YKEAWPSSLADITGHSLDSLTECVKCLHEVHRKGEAASQKAAYNKYKLNLWKNVS 491
++WP SL TG++L++L C+ LH+ + + +Q++ KYK + + VS
Sbjct: 199 -GQSWPESLVQKTGYTLETLKPCLLDLHQTYLRAPQHAQQSIREKYKNSKYHGVS 252
>pdb|1VIN|A Chain A, Bovine Cyclin A3
Length = 268
Score = 241 bits (615), Expect = 8e-64, Method: Compositional matrix adjust.
Identities = 127/295 (43%), Positives = 178/295 (60%), Gaps = 50/295 (16%)
Query: 198 DYRDDIYQYLLKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAI 257
DY +DI+ YL + E + +PK YM+KQ DI + MR++LVDW
Sbjct: 7 DYHEDIHTYLREMEVKCKPKVGYMKKQPDITNSMRAILVDW------------------- 47
Query: 258 NYVDRFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSV 317
++EV EEYK+ NETLHLA+NY+DRFLS MSV
Sbjct: 48 -----------------------------LVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 78
Query: 318 VRSKLQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNFDLNI 377
+R KLQL+GT A+ +ASK+EEIYPPEV EFVYITDDTYTKKQ+L+ME L+LKVL FDL
Sbjct: 79 LRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLAFDLAA 138
Query: 378 PTVHSFICHITVSGH-LDQSVLYLAQYLSELALVSGDPFLQFLPSLIACSAIALARYCLD 436
PT++ F+ + + V LA +L EL+L+ DP+L++LPS+IA +A LA Y +
Sbjct: 139 PTINQFLTQYFLHQQPANCKVESLAMFLGELSLIDADPYLKYLPSVIAAAAFHLALYTVT 198
Query: 437 YKEAWPSSLADITGHSLDSLTECVKCLHEVHRKGEAASQKAAYNKYKLNLWKNVS 491
++WP SL TG++L++L C+ LH+ + + +Q++ KYK + + VS
Sbjct: 199 -GQSWPESLVQKTGYTLETLKPCLLDLHQTYLRAPQHAQQSIREKYKNSKYHGVS 252
>pdb|4BCQ|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 239 bits (610), Expect = 2e-63, Method: Compositional matrix adjust.
Identities = 129/295 (43%), Positives = 177/295 (60%), Gaps = 50/295 (16%)
Query: 198 DYRDDIYQYLLKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAI 257
DY +DI+ YL + E + +PK YM+KQ DI + MR++LVDW
Sbjct: 7 DYHEDIHTYLREMEVKCKPKVGYMKKQPDITNSMRAILVDW------------------- 47
Query: 258 NYVDRFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSV 317
++EV EEYK+ NETLHLA+NY+DRFLS MSV
Sbjct: 48 -----------------------------LVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 78
Query: 318 VRSKLQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNFDLNI 377
+R KLQL+GT A+ +ASK+EEIYPPEV EFVYITDDTYTKKQ+L+ME L+LKVL FDL
Sbjct: 79 LRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAA 138
Query: 378 PTVHSFICHITVSGH-LDQSVLYLAQYLSELALVSGDPFLQFLPSLIACSAIALARYCLD 436
PTV+ F+ + + V LA +L EL+L+ DP+L++LPS+IA +A LA Y +
Sbjct: 139 PTVNQFLTQYFLHQQPANCKVESLAMFLGELSLIDADPYLKYLPSVIAAAAFHLALYTVT 198
Query: 437 YKEAWPSSLADITGHSLDSLTECVKCLHEVHRKGEAASQKAAYNKYKLNLWKNVS 491
++WP SL TG++L+SL + LH+ + K +Q++ KYK + + VS
Sbjct: 199 -GQSWPESLIRKTGYTLESLKPMLLDLHQTYLKAPQHAQQSIREKYKNSKYHGVS 252
>pdb|4BCO|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 234 bits (596), Expect = 1e-61, Method: Compositional matrix adjust.
Identities = 128/295 (43%), Positives = 175/295 (59%), Gaps = 50/295 (16%)
Query: 198 DYRDDIYQYLLKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAI 257
DY +DI+ YL + E + +PK YM+KQ DI + MR
Sbjct: 7 DYHEDIHTYLREMEVKCKPKVGYMKKQPDITNSMR------------------------- 41
Query: 258 NYVDRFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSV 317
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV
Sbjct: 42 -----------------------AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 78
Query: 318 VRSKLQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNFDLNI 377
+R KLQL+GT A+ +ASK+EEIYPPEV EFVYITDDTYTKKQ+L+ME L+LKVL FDL
Sbjct: 79 LRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAA 138
Query: 378 PTVHSFICHITVSGH-LDQSVLYLAQYLSELALVSGDPFLQFLPSLIACSAIALARYCLD 436
PTV+ F+ + + V LA +L EL+L+ DP+L++LPS+IA +A LA Y +
Sbjct: 139 PTVNQFLTQYFLHQQPANCKVESLAMFLGELSLIDADPYLKYLPSVIAAAAFHLALYTVT 198
Query: 437 YKEAWPSSLADITGHSLDSLTECVKCLHEVHRKGEAASQKAAYNKYKLNLWKNVS 491
++WP SL TG++L+SL C+ LH+ + K +Q++ KYK + + VS
Sbjct: 199 -GQSWPESLIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKYKNSKYHGVS 252
>pdb|1OGU|B Chain B, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|D Chain D, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|2IW6|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW8|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW9|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 260
Score = 234 bits (596), Expect = 1e-61, Method: Compositional matrix adjust.
Identities = 128/299 (42%), Positives = 176/299 (58%), Gaps = 50/299 (16%)
Query: 194 INADDYRDDIYQYLLKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETL 253
+ DY +DI+ YL + E + +PK YM+KQ DI + MR
Sbjct: 1 MEVPDYHEDIHTYLREMEVKCKPKVGYMKKQPDITNSMR--------------------- 39
Query: 254 HLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLS 313
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS
Sbjct: 40 ---------------------------AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLS 72
Query: 314 LMSVVRSKLQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNF 373
MSV+R KLQL+GT A+ +ASK+EEIYPPEV EFVYITDDTYTKKQ+L+ME L+LKVL F
Sbjct: 73 SMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTF 132
Query: 374 DLNIPTVHSFICHITVSGH-LDQSVLYLAQYLSELALVSGDPFLQFLPSLIACSAIALAR 432
DL PTV+ F+ + + V LA +L EL+L+ DP+L++LPS+IA +A LA
Sbjct: 133 DLAAPTVNQFLTQYFLHQQPANCKVESLAMFLGELSLIDADPYLKYLPSVIAGAAFHLAL 192
Query: 433 YCLDYKEAWPSSLADITGHSLDSLTECVKCLHEVHRKGEAASQKAAYNKYKLNLWKNVS 491
Y + ++WP SL TG++L+SL C+ LH+ + K +Q++ KYK + + VS
Sbjct: 193 YTVT-GQSWPESLIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKYKNSKYHGVS 250
>pdb|2X1N|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
Length = 261
Score = 233 bits (595), Expect = 1e-61, Method: Compositional matrix adjust.
Identities = 128/295 (43%), Positives = 175/295 (59%), Gaps = 50/295 (16%)
Query: 198 DYRDDIYQYLLKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAI 257
DY +DI+ YL + E + +PK YM+KQ DI + MR
Sbjct: 6 DYHEDIHTYLREMEVKCKPKVGYMKKQPDITNSMR------------------------- 40
Query: 258 NYVDRFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSV 317
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV
Sbjct: 41 -----------------------AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 77
Query: 318 VRSKLQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNFDLNI 377
+R KLQL+GT A+ +ASK+EEIYPPEV EFVYITDDTYTKKQ+L+ME L+LKVL FDL
Sbjct: 78 LRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAA 137
Query: 378 PTVHSFICHITVSGH-LDQSVLYLAQYLSELALVSGDPFLQFLPSLIACSAIALARYCLD 436
PTV+ F+ + + V LA +L EL+L+ DP+L++LPS+IA +A LA Y +
Sbjct: 138 PTVNQFLTQYFLHQQPANCKVESLAMFLGELSLIDADPYLKYLPSVIAGAAFHLALYTVT 197
Query: 437 YKEAWPSSLADITGHSLDSLTECVKCLHEVHRKGEAASQKAAYNKYKLNLWKNVS 491
++WP SL TG++L+SL C+ LH+ + K +Q++ KYK + + VS
Sbjct: 198 -GQSWPESLIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKYKNSKYHGVS 251
>pdb|1QMZ|B Chain B, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|D Chain D, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1H24|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|B Chain B, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|D Chain D, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2C5N|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2UUE|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2WMA|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 259
Score = 233 bits (595), Expect = 1e-61, Method: Compositional matrix adjust.
Identities = 128/295 (43%), Positives = 175/295 (59%), Gaps = 50/295 (16%)
Query: 198 DYRDDIYQYLLKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAI 257
DY +DI+ YL + E + +PK YM+KQ DI + MR
Sbjct: 4 DYHEDIHTYLREMEVKCKPKVGYMKKQPDITNSMR------------------------- 38
Query: 258 NYVDRFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSV 317
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV
Sbjct: 39 -----------------------AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 75
Query: 318 VRSKLQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNFDLNI 377
+R KLQL+GT A+ +ASK+EEIYPPEV EFVYITDDTYTKKQ+L+ME L+LKVL FDL
Sbjct: 76 LRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAA 135
Query: 378 PTVHSFICHITVSGH-LDQSVLYLAQYLSELALVSGDPFLQFLPSLIACSAIALARYCLD 436
PTV+ F+ + + V LA +L EL+L+ DP+L++LPS+IA +A LA Y +
Sbjct: 136 PTVNQFLTQYFLHQQPANCKVESLAMFLGELSLIDADPYLKYLPSVIAGAAFHLALYTVT 195
Query: 437 YKEAWPSSLADITGHSLDSLTECVKCLHEVHRKGEAASQKAAYNKYKLNLWKNVS 491
++WP SL TG++L+SL C+ LH+ + K +Q++ KYK + + VS
Sbjct: 196 -GQSWPESLIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKYKNSKYHGVS 249
>pdb|1FIN|B Chain B, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|D Chain D, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1JSU|B Chain B, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FVV|B Chain B, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|D Chain D, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1OKV|B Chain B, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|D Chain D, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|B Chain B, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|D Chain D, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|B Chain B, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|D Chain D, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|B Chain B, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|D Chain D, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1URC|B Chain B, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|D Chain D, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|2C5O|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2CCH|B Chain B, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|D Chain D, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2I40|B Chain B, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|D Chain D, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|3EID|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|B Chain B, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|D Chain D, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2WEV|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
Length = 260
Score = 233 bits (595), Expect = 1e-61, Method: Compositional matrix adjust.
Identities = 128/295 (43%), Positives = 175/295 (59%), Gaps = 50/295 (16%)
Query: 198 DYRDDIYQYLLKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAI 257
DY +DI+ YL + E + +PK YM+KQ DI + MR
Sbjct: 5 DYHEDIHTYLREMEVKCKPKVGYMKKQPDITNSMR------------------------- 39
Query: 258 NYVDRFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSV 317
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV
Sbjct: 40 -----------------------AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 76
Query: 318 VRSKLQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNFDLNI 377
+R KLQL+GT A+ +ASK+EEIYPPEV EFVYITDDTYTKKQ+L+ME L+LKVL FDL
Sbjct: 77 LRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAA 136
Query: 378 PTVHSFICHITVSGH-LDQSVLYLAQYLSELALVSGDPFLQFLPSLIACSAIALARYCLD 436
PTV+ F+ + + V LA +L EL+L+ DP+L++LPS+IA +A LA Y +
Sbjct: 137 PTVNQFLTQYFLHQQPANCKVESLAMFLGELSLIDADPYLKYLPSVIAGAAFHLALYTVT 196
Query: 437 YKEAWPSSLADITGHSLDSLTECVKCLHEVHRKGEAASQKAAYNKYKLNLWKNVS 491
++WP SL TG++L+SL C+ LH+ + K +Q++ KYK + + VS
Sbjct: 197 -GQSWPESLIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKYKNSKYHGVS 250
>pdb|1VYW|B Chain B, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|D Chain D, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|B Chain B, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|D Chain D, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|B Chain B, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|D Chain D, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|B Chain B, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|D Chain D, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|B Chain B, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|D Chain D, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|B Chain B, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|D Chain D, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|B Chain B, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|D Chain D, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|B Chain B, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|D Chain D, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 265
Score = 233 bits (595), Expect = 1e-61, Method: Compositional matrix adjust.
Identities = 128/295 (43%), Positives = 175/295 (59%), Gaps = 50/295 (16%)
Query: 198 DYRDDIYQYLLKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAI 257
DY +DI+ YL + E + +PK YM+KQ DI + MR
Sbjct: 10 DYHEDIHTYLREMEVKCKPKVGYMKKQPDITNSMR------------------------- 44
Query: 258 NYVDRFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSV 317
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV
Sbjct: 45 -----------------------AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 81
Query: 318 VRSKLQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNFDLNI 377
+R KLQL+GT A+ +ASK+EEIYPPEV EFVYITDDTYTKKQ+L+ME L+LKVL FDL
Sbjct: 82 LRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAA 141
Query: 378 PTVHSFICHITVSGH-LDQSVLYLAQYLSELALVSGDPFLQFLPSLIACSAIALARYCLD 436
PTV+ F+ + + V LA +L EL+L+ DP+L++LPS+IA +A LA Y +
Sbjct: 142 PTVNQFLTQYFLHQQPANCKVESLAMFLGELSLIDADPYLKYLPSVIAGAAFHLALYTVT 201
Query: 437 YKEAWPSSLADITGHSLDSLTECVKCLHEVHRKGEAASQKAAYNKYKLNLWKNVS 491
++WP SL TG++L+SL C+ LH+ + K +Q++ KYK + + VS
Sbjct: 202 -GQSWPESLIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKYKNSKYHGVS 255
>pdb|1JST|B Chain B, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|D Chain D, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1GY3|B Chain B, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|D Chain D, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1H1P|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1P5E|B Chain B, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|D Chain D, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1PKD|B Chain B, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|D Chain D, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|2C6T|B Chain B, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|D Chain D, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|B Chain B, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|D Chain D, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CCI|B Chain B, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|D Chain D, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2UZB|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4EOI|B Chain B, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|D Chain D, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOJ|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOK|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOM|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EON|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOO|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOP|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOQ|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOR|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOS|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 258
Score = 233 bits (595), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 128/295 (43%), Positives = 175/295 (59%), Gaps = 50/295 (16%)
Query: 198 DYRDDIYQYLLKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAI 257
DY +DI+ YL + E + +PK YM+KQ DI + MR
Sbjct: 3 DYHEDIHTYLREMEVKCKPKVGYMKKQPDITNSMR------------------------- 37
Query: 258 NYVDRFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSV 317
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV
Sbjct: 38 -----------------------AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 74
Query: 318 VRSKLQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNFDLNI 377
+R KLQL+GT A+ +ASK+EEIYPPEV EFVYITDDTYTKKQ+L+ME L+LKVL FDL
Sbjct: 75 LRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAA 134
Query: 378 PTVHSFICHITVSGH-LDQSVLYLAQYLSELALVSGDPFLQFLPSLIACSAIALARYCLD 436
PTV+ F+ + + V LA +L EL+L+ DP+L++LPS+IA +A LA Y +
Sbjct: 135 PTVNQFLTQYFLHQQPANCKVESLAMFLGELSLIDADPYLKYLPSVIAGAAFHLALYTVT 194
Query: 437 YKEAWPSSLADITGHSLDSLTECVKCLHEVHRKGEAASQKAAYNKYKLNLWKNVS 491
++WP SL TG++L+SL C+ LH+ + K +Q++ KYK + + VS
Sbjct: 195 -GQSWPESLIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKYKNSKYHGVS 248
>pdb|3F5X|B Chain B, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|D Chain D, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
Length = 256
Score = 233 bits (594), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 128/295 (43%), Positives = 175/295 (59%), Gaps = 50/295 (16%)
Query: 198 DYRDDIYQYLLKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAI 257
DY +DI+ YL + E + +PK YM+KQ DI + MR
Sbjct: 1 DYHEDIHTYLREMEVKCKPKVGYMKKQPDITNSMR------------------------- 35
Query: 258 NYVDRFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSV 317
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV
Sbjct: 36 -----------------------AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 72
Query: 318 VRSKLQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNFDLNI 377
+R KLQL+GT A+ +ASK+EEIYPPEV EFVYITDDTYTKKQ+L+ME L+LKVL FDL
Sbjct: 73 LRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAA 132
Query: 378 PTVHSFICHITVSGH-LDQSVLYLAQYLSELALVSGDPFLQFLPSLIACSAIALARYCLD 436
PTV+ F+ + + V LA +L EL+L+ DP+L++LPS+IA +A LA Y +
Sbjct: 133 PTVNQFLTQYFLHQQPANCKVESLAMFLGELSLIDADPYLKYLPSVIAGAAFHLALYTVT 192
Query: 437 YKEAWPSSLADITGHSLDSLTECVKCLHEVHRKGEAASQKAAYNKYKLNLWKNVS 491
++WP SL TG++L+SL C+ LH+ + K +Q++ KYK + + VS
Sbjct: 193 -GQSWPESLIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKYKNSKYHGVS 246
>pdb|1E9H|B Chain B, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|D Chain D, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
Length = 261
Score = 233 bits (594), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 128/295 (43%), Positives = 175/295 (59%), Gaps = 50/295 (16%)
Query: 198 DYRDDIYQYLLKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAI 257
DY +DI+ YL + E + +PK YM+KQ DI + MR
Sbjct: 3 DYHEDIHTYLREMEVKCKPKVGYMKKQPDITNSMR------------------------- 37
Query: 258 NYVDRFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSV 317
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV
Sbjct: 38 -----------------------AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 74
Query: 318 VRSKLQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNFDLNI 377
+R KLQL+GT A+ +ASK+EEIYPPEV EFVYITDDTYTKKQ+L+ME L+LKVL FDL
Sbjct: 75 LRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAA 134
Query: 378 PTVHSFICHITVSGH-LDQSVLYLAQYLSELALVSGDPFLQFLPSLIACSAIALARYCLD 436
PTV+ F+ + + V LA +L EL+L+ DP+L++LPS+IA +A LA Y +
Sbjct: 135 PTVNQFLTQYFLHQQPANCKVESLAMFLGELSLIDADPYLKYLPSVIAGAAFHLALYTVT 194
Query: 437 YKEAWPSSLADITGHSLDSLTECVKCLHEVHRKGEAASQKAAYNKYKLNLWKNVS 491
++WP SL TG++L+SL C+ LH+ + K +Q++ KYK + + VS
Sbjct: 195 -GQSWPESLIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKYKNSKYHGVS 248
>pdb|4BCQ|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 230 bits (586), Expect = 2e-60, Method: Compositional matrix adjust.
Identities = 126/295 (42%), Positives = 174/295 (58%), Gaps = 50/295 (16%)
Query: 198 DYRDDIYQYLLKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAI 257
DY +DI+ YL + E + +PK YM+KQ DI + MR
Sbjct: 7 DYHEDIHTYLREMEVKCKPKVGYMKKQPDITNSMR------------------------- 41
Query: 258 NYVDRFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSV 317
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV
Sbjct: 42 -----------------------AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 78
Query: 318 VRSKLQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNFDLNI 377
+R KLQL+GT A+ +ASK+EEIYPPEV EFVYITDDTYTKKQ+L+ME L+LKVL FDL
Sbjct: 79 LRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAA 138
Query: 378 PTVHSFICHITVSGH-LDQSVLYLAQYLSELALVSGDPFLQFLPSLIACSAIALARYCLD 436
PTV+ F+ + + V LA +L EL+L+ DP+L++LPS+IA +A LA Y +
Sbjct: 139 PTVNQFLTQYFLHQQPANCKVESLAMFLGELSLIDADPYLKYLPSVIAAAAFHLALYTVT 198
Query: 437 YKEAWPSSLADITGHSLDSLTECVKCLHEVHRKGEAASQKAAYNKYKLNLWKNVS 491
++WP SL TG++L++ C+ LH+ + K +Q++ KYK + + VS
Sbjct: 199 -GQSWPESLIRKTGYTLETSKPCMLDLHQTYLKAPQHAQQSIREKYKNSKYHGVS 252
>pdb|2B9R|A Chain A, Crystal Structure Of Human Cyclin B1
pdb|2B9R|B Chain B, Crystal Structure Of Human Cyclin B1
Length = 269
Score = 136 bits (342), Expect = 3e-32, Method: Compositional matrix adjust.
Identities = 85/270 (31%), Positives = 135/270 (50%), Gaps = 55/270 (20%)
Query: 196 ADDYRDDIYQYL--LKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETL 253
+ +Y DIY YL L+ + +RPK R ++ MR++L+DWL
Sbjct: 3 SSEYVKDIYAYLRQLEAAQAVRPKYLLGR---EVTGNMRAILIDWL-------------- 45
Query: 254 HLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLS 313
++V ++++ ET+++ ++ +DRF+
Sbjct: 46 ----------------------------------VQVQMKFRLLQETMYMTVSIIDRFMQ 71
Query: 314 LMSVVRSKLQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNF 373
SV + LQL+G TA+F+ASKYEE+YPPE+ +F ++TD+TYTK Q+ +ME IL+ LNF
Sbjct: 72 NNSVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNF 131
Query: 374 DLNIPTVHSFICHITVSGHLDQSVLYLAQYLSELALVSGDPFLQFLPSLIACSAIALARY 433
L P F+ + G +D LA+YL EL ++ D + F PS IA A +LA
Sbjct: 132 GLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYD-MVHFPPSQIAAGAFSLALK 190
Query: 434 CLDYKEAWPSSLADITGHSLDSLTECVKCL 463
LD E W +L ++ +SL ++ L
Sbjct: 191 ILDNGE-WTPTLQHYLSYTEESLLPVMQHL 219
>pdb|2JGZ|B Chain B, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 260
Score = 131 bits (329), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 84/268 (31%), Positives = 133/268 (49%), Gaps = 55/268 (20%)
Query: 198 DYRDDIYQYL--LKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETLHL 255
+Y DIY YL L+ E+ +RPK R ++ MR++L+DW
Sbjct: 3 EYVKDIYAYLRQLEEEQAVRPKYLLGR---EVTGNMRAILIDW----------------- 42
Query: 256 AINYVDRFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLM 315
+++V ++++ ET+++ ++ +DRF+
Sbjct: 43 -------------------------------LVQVQMKFRLLQETMYMTVSIIDRFMQNN 71
Query: 316 SVVRSKLQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNFDL 375
V + LQL+G TA+F+ASKYEE+YPPE+ +F ++TD+TYTK Q+ +ME IL+ LNF L
Sbjct: 72 CVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGL 131
Query: 376 NIPTVHSFICHITVSGHLDQSVLYLAQYLSELALVSGDPFLQFLPSLIACSAIALARYCL 435
P F+ + G +D LA+YL EL ++ D + F PS IA A LA L
Sbjct: 132 GRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYD-MVHFPPSQIAAGAFCLALKIL 190
Query: 436 DYKEAWPSSLADITGHSLDSLTECVKCL 463
D E W +L ++ +SL ++ L
Sbjct: 191 DNGE-WTPTLQHYLSYTEESLLPVMQHL 217
>pdb|1W98|B Chain B, The Structural Basis Of Cdk2 Activation By Cyclin E
Length = 283
Score = 92.8 bits (229), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 60/195 (30%), Positives = 112/195 (57%), Gaps = 21/195 (10%)
Query: 281 ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLM-SVVRSKLQLLGTTALFVASKYEEI 339
A+ + ++EV E YK+H ET +LA ++ DR+++ +VV++ LQL+G ++LF+A+K EEI
Sbjct: 51 AILLDWLMEVCEVYKLHRETFYLAQDFFDRYMATQENVVKTLLQLIGISSLFIAAKLEEI 110
Query: 340 YPPEVNEFVYITDDTYTKKQLLKMETLILKVLNFDLNIPTVHSFI-CHITVSGHLDQSVL 398
YPP++++F Y+TD + ++L ME +I+K L + L+ T+ S++ ++ V+ D +
Sbjct: 111 YPPKLHQFAYVTDGACSGDEILTMELMIMKALKWRLSPLTIVSWLNVYMQVAYLNDLHEV 170
Query: 399 YLAQY----------LSELALVSGDPFLQFLPSLIACSAIALARYCLDYKEAWPSSLADI 448
L QY L +L ++ D L+F ++A SA+ Y + + +
Sbjct: 171 LLPQYPQQIFIQIAELLDLCVLDVD-CLEFPYGILAASAL--------YHFSSSELMQKV 221
Query: 449 TGHSLDSLTECVKCL 463
+G+ + CVK +
Sbjct: 222 SGYQWCDIENCVKWM 236
>pdb|3G33|B Chain B, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|D Chain D, Crystal Structure Of Cdk4CYCLIN D3
Length = 306
Score = 88.6 bits (218), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 73/265 (27%), Positives = 108/265 (40%), Gaps = 56/265 (21%)
Query: 203 IYQYLLKCERRIRPKANYMRK-QNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAINYVD 261
+ Q LL+ E R P+A+Y + Q +I MR +L W++
Sbjct: 41 VLQSLLRLEERYVPRASYFQCVQREIKPHMRKMLAYWML--------------------- 79
Query: 262 RFLSLMSVVRSKLQLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSK 321
EV EE + E LA+NY+DR+LS + +++
Sbjct: 80 ---------------------------EVCEEQRCEEEVFPLAMNYLDRYLSCVPTRKAQ 112
Query: 322 LQLLGTTALFVASKYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNFDLNIPTVH 381
LQLLG + +ASK E P + + TD + +QL E L+L L +DL H
Sbjct: 113 LQLLGAVCMLLASKLRETTPLTIEKLCIYTDHAVSPRQLRDWEVLVLGKLKWDLAAVIAH 172
Query: 382 SFICHI--TVSGHLDQSVLYLAQYLSELALVSGD-PFLQFLPSLIACSAIALA----RYC 434
F+ I +S D+ L + LAL + D F + PS+IA +I A C
Sbjct: 173 DFLAFILHRLSLPRDRQALVKKHAQTFLALCATDYTFAMYPPSMIATGSIGAAVQGLGAC 232
Query: 435 LDYKEAWPSSLADITGHSLDSLTEC 459
+ LA ITG +D L C
Sbjct: 233 SMSGDELTELLAGITGTEVDCLRAC 257
>pdb|2W96|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W99|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9F|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 271
Score = 79.0 bits (193), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 1/93 (1%)
Query: 195 NADDYRDDIYQYLLKCERRIRPKANYMRK-QNDINSEMRSVLVDWLIEVAEEYKMHNETL 253
+A+ D + + +LK E P +Y + Q ++ MR ++ W++EV EE K E
Sbjct: 19 DANLLNDRVLRAMLKAEETCAPSVSYFKCVQKEVLPSMRKIVATWMLEVCEEQKCEEEVF 78
Query: 254 HLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 286
LA+NY+DRFLSL V +S+LQLLG T +FVAS
Sbjct: 79 PLAMNYLDRFLSLEPVKKSRLQLLGATCMFVAS 111
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 45/101 (44%), Positives = 63/101 (62%)
Query: 287 IIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASKYEEIYPPEVNE 346
++EV EE K E LA+NY+DRFLSL V +S+LQLLG T +FVASK +E P +
Sbjct: 64 MLEVCEEQKCEEEVFPLAMNYLDRFLSLEPVKKSRLQLLGATCMFVASKMKETIPLTAEK 123
Query: 347 FVYITDDTYTKKQLLKMETLILKVLNFDLNIPTVHSFICHI 387
TD++ ++LL+ME L++ L ++L T H FI H
Sbjct: 124 LCIYTDNSIRPEELLQMELLLVNKLKWNLAAMTPHDFIEHF 164
>pdb|2W9Z|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 257
Score = 79.0 bits (193), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 1/93 (1%)
Query: 195 NADDYRDDIYQYLLKCERRIRPKANYMRK-QNDINSEMRSVLVDWLIEVAEEYKMHNETL 253
+A+ D + + +LK E P +Y + Q ++ MR ++ W++EV EE K E
Sbjct: 5 DANLLNDRVLRAMLKAEETCAPSVSYFKCVQKEVLPSMRKIVATWMLEVCEEQKCEEEVF 64
Query: 254 HLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 286
LA+NY+DRFLSL V +S+LQLLG T +FVAS
Sbjct: 65 PLAMNYLDRFLSLEPVKKSRLQLLGATCMFVAS 97
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 45/101 (44%), Positives = 63/101 (62%)
Query: 287 IIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASKYEEIYPPEVNE 346
++EV EE K E LA+NY+DRFLSL V +S+LQLLG T +FVASK +E P +
Sbjct: 50 MLEVCEEQKCEEEVFPLAMNYLDRFLSLEPVKKSRLQLLGATCMFVASKMKETIPLTAEK 109
Query: 347 FVYITDDTYTKKQLLKMETLILKVLNFDLNIPTVHSFICHI 387
TD++ ++LL+ME L++ L ++L T H FI H
Sbjct: 110 LCIYTDNSIRPEELLQMELLLVNKLKWNLAAMTPHDFIEHF 150
>pdb|2PK2|A Chain A, Cyclin Box Structure Of The P-Tefb Subunit Cyclin T1
Derived From A Fusion Complex With Eiav Tat
pdb|2PK2|B Chain B, Cyclin Box Structure Of The P-Tefb Subunit Cyclin T1
Derived From A Fusion Complex With Eiav Tat
pdb|2PK2|C Chain C, Cyclin Box Structure Of The P-Tefb Subunit Cyclin T1
Derived From A Fusion Complex With Eiav Tat
pdb|2PK2|D Chain D, Cyclin Box Structure Of The P-Tefb Subunit Cyclin T1
Derived From A Fusion Complex With Eiav Tat
Length = 358
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 52/186 (27%), Positives = 80/186 (43%), Gaps = 33/186 (17%)
Query: 300 TLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASKYEEIYPPEVNEFVYIT-------- 351
T++ AI Y+ RF + S R + ALF+A+K EE P ++ + +
Sbjct: 58 TINTAIVYMHRFYMIQSFTRFPGNSVAPAALFLAAKVEE-QPKKLEHVIKVAHTCLHPQE 116
Query: 352 --DDTYTK------KQLLKMETLILKVLNFDLNI--PTVHSFICH--ITVSGHLDQSVLY 399
DT ++ + L+ +E++IL+ L F+L I P H C + S L Q+ +
Sbjct: 117 SLPDTRSEAYLQQVQDLVILESIILQTLGFELTIDHPHTHVVKCTQLVRASKDLAQTSYF 176
Query: 400 LAQYLSELALVSGDPFLQFLPSLIACSAIALA--------RYCLDYKEAWPSSLADITGH 451
+A L S LQ+ P ++AC I LA D K W A +T
Sbjct: 177 MATNSLHLTTFS----LQYTPPVVACVCIHLACKWSNWEIPVSTDGKHWWEYVDATVTLE 232
Query: 452 SLDSLT 457
LD LT
Sbjct: 233 LLDELT 238
>pdb|2W2H|A Chain A, Structural Basis Of Transcription Activation By The Cyclin
T1-Tat-Tar Rna Complex From Eiav
pdb|2W2H|B Chain B, Structural Basis Of Transcription Activation By The Cyclin
T1-Tat-Tar Rna Complex From Eiav
Length = 264
Score = 48.5 bits (114), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 52/186 (27%), Positives = 80/186 (43%), Gaps = 33/186 (17%)
Query: 300 TLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASKYEEIYPPEVNEFVYIT-------- 351
T++ AI Y+ RF + S R + ALF+A+K EE P ++ + +
Sbjct: 55 TINTAIVYMHRFYMIQSFTRFHRNSVAPAALFLAAKVEE-QPKKLEHVIKVAHTCLHPQE 113
Query: 352 --DDTYTK------KQLLKMETLILKVLNFDLNI--PTVHSFICH--ITVSGHLDQSVLY 399
DT ++ + L+ +E++IL+ L F+L I P H C + S L Q+ +
Sbjct: 114 SLPDTRSEAYLQQVQDLVILESIILQTLGFELTIDHPHTHVVKCTQLVRASKDLAQTSYF 173
Query: 400 LAQYLSELALVSGDPFLQFLPSLIACSAIALA--------RYCLDYKEAWPSSLADITGH 451
+A L S LQ+ P ++AC I LA D K W A +T
Sbjct: 174 MATNSLHLTTFS----LQYTPPVVACVCIHLACKWSNWEIPVSTDGKHWWEYVDATVTLE 229
Query: 452 SLDSLT 457
LD LT
Sbjct: 230 LLDELT 235
>pdb|3MI9|B Chain B, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|B Chain B, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 266
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 51/186 (27%), Positives = 80/186 (43%), Gaps = 33/186 (17%)
Query: 300 TLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASKYEEIYPPEVNEFVYIT-------- 351
T++ AI Y+ RF + S + + ALF+A+K EE P ++ + +
Sbjct: 58 TINTAIVYMHRFYMIQSFTQFPGNSVAPAALFLAAKVEE-QPKKLEHVIKVAHTCLHPQE 116
Query: 352 --DDTYTK------KQLLKMETLILKVLNFDLNI--PTVHSFICH--ITVSGHLDQSVLY 399
DT ++ + L+ +E++IL+ L F+L I P H C + S L Q+ +
Sbjct: 117 SLPDTRSEAYLQQVQDLVILESIILQTLGFELTIDHPHTHVVKCTQLVRASKDLAQTSYF 176
Query: 400 LAQYLSELALVSGDPFLQFLPSLIACSAIALA--------RYCLDYKEAWPSSLADITGH 451
+A L S LQ+ P ++AC I LA D K W A +T
Sbjct: 177 MATNSLHLTTFS----LQYTPPVVACVCIHLACKWSNWEIPVSTDGKHWWEYVDATVTLE 232
Query: 452 SLDSLT 457
LD LT
Sbjct: 233 LLDELT 238
>pdb|2IVX|A Chain A, Crystal Structure Of Human Cyclin T2 At 1.8 A Resolution
(Casp Target)
pdb|2IVX|B Chain B, Crystal Structure Of Human Cyclin T2 At 1.8 A Resolution
(Casp Target)
Length = 257
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 40/162 (24%), Positives = 77/162 (47%), Gaps = 19/162 (11%)
Query: 287 IIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASKYEE-------- 338
I E+ + + T++ AI Y+ RF S + ++ +TALF+A+K EE
Sbjct: 38 IQEMGQRLNVSQLTINTAIVYMHRFYMHHSFTKFNKNIISSTALFLAAKVEEQARKLEHV 97
Query: 339 -------IYPPEVNEFVYITDDTYTK--KQLLKMETLILKVLNFDLNIPTVHSFICHITV 389
++P E + D Y + ++L+ +ET++L+ L F++ I H+ + T
Sbjct: 98 IKVAHACLHPLE--PLLDTKCDAYLQQTRELVILETIMLQTLGFEITIEHPHTDVVKCTQ 155
Query: 390 SGHLDQSVLYLAQYLSELALVSGDPFLQFLPSLIACSAIALA 431
+ + + +++ +L LQ+ P++IAC I LA
Sbjct: 156 LVRASKDLAQTSYFMATNSLHLTTFCLQYKPTVIACVCIHLA 197
>pdb|3TNH|B Chain B, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|B Chain B, Structure Of Cdk9CYCLIN T F241L
Length = 259
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 51/186 (27%), Positives = 80/186 (43%), Gaps = 33/186 (17%)
Query: 300 TLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASKYEEIYPPEVNEFVYIT-------- 351
T++ AI Y+ RF + S + + ALF+A+K EE P ++ + +
Sbjct: 58 TINTAIVYMHRFYMIQSFTQFPGNSVAPAALFLAAKVEE-QPKKLEHVIKVAHTCLHPQE 116
Query: 352 --DDTYTK------KQLLKMETLILKVLNFDLNI--PTVHSFICH--ITVSGHLDQSVLY 399
DT ++ + L+ +E++IL+ L F+L I P H C + S L Q+ +
Sbjct: 117 SLPDTRSEAYLQQVQDLVILESIILQTLGFELTIDHPHTHVVKCTQLVRASKDLAQTSYF 176
Query: 400 LAQYLSELALVSGDPFLQFLPSLIACSAIALA--------RYCLDYKEAWPSSLADITGH 451
+A L S LQ+ P ++AC I LA D K W A +T
Sbjct: 177 MATNSLHLTTFS----LQYTPPVVACVCIHLACKWSNWEIPVSTDGKHWWEYVDATVTLE 232
Query: 452 SLDSLT 457
LD LT
Sbjct: 233 LLDELT 238
>pdb|3BLH|B Chain B, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|B Chain B, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|B Chain B, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|B Chain B, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|B Chain B, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|B Chain B, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|4EC8|B Chain B, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|B Chain B, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
pdb|4BCF|B Chain B, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCH|B Chain B, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|B Chain B, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|B Chain B, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 260
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 51/186 (27%), Positives = 79/186 (42%), Gaps = 33/186 (17%)
Query: 300 TLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASKYEEIYPPEVNEFVYIT-------- 351
T++ AI Y+ RF + S R + ALF+A+K E P ++ + +
Sbjct: 59 TINTAIVYMHRFYMIQSFTRFPGNSVAPAALFLAAKVEG-QPKKLEHVIKVAHTCLHPQE 117
Query: 352 --DDTYTK------KQLLKMETLILKVLNFDLNI--PTVHSFICH--ITVSGHLDQSVLY 399
DT ++ + L+ +E++IL+ L F+L I P H C + S L Q+ +
Sbjct: 118 SLPDTRSEAYLQQVQDLVILESIILQTLGFELTIDHPHTHVVKCTQLVRASKDLAQTSYF 177
Query: 400 LAQYLSELALVSGDPFLQFLPSLIACSAIALA--------RYCLDYKEAWPSSLADITGH 451
+A L S LQ+ P ++AC I LA D K W A +T
Sbjct: 178 MATNSLHLTTFS----LQYTPPVVACVCIHLACKWSNWEIPVSTDGKHWWEYVDATVTLE 233
Query: 452 SLDSLT 457
LD LT
Sbjct: 234 LLDELT 239
>pdb|2I53|A Chain A, Crystal Structure Of Cyclin K
Length = 258
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 43/175 (24%), Positives = 73/175 (41%), Gaps = 22/175 (12%)
Query: 287 IIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASKYEEIYPPEVN- 345
I +V +H +TL I Y RF S + + G LF+A K EE P +
Sbjct: 48 IFDVGTRLGLHYDTLATGIIYFHRFYMFHSFKQFPRYVTGACCLFLAGKVEET-PKKCKD 106
Query: 346 ------------EFVYITDDTYTKKQLLKMETLILKVLNFDLNIPTVHSFICHITVSGHL 393
+F DD K++++ +E ++L+ + FDL + + F+
Sbjct: 107 IIKTARSLLNDVQFGQFGDD--PKEEVMVLERILLQTIKFDLQVEHPYQFLLKYAKQLKG 164
Query: 394 D----QSVLYLAQYLSELALVSGDPFLQFLPSLIACSAIALA-RYCLDYKEAWPS 443
D Q ++ +A +L + LQ+ P +IA + + LA R C + W S
Sbjct: 165 DKNKIQKLVQMAWTFVNDSLCTTLS-LQWEPEIIAVAVMYLAGRLCKFEIQEWTS 218
>pdb|1BU2|A Chain A, X-Ray Structure Of A Viral Cyclin From Herpesvirus Saimiri
Length = 229
Score = 36.2 bits (82), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 19/94 (20%), Positives = 44/94 (46%), Gaps = 1/94 (1%)
Query: 208 LKCERRIRPKANYMRK-QNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAINYVDRFLSL 266
LK + PK + + Q ++ + R++L+ W+ + E +++ L+++ +DR+L
Sbjct: 6 LKLRELLLPKFTSLWEIQTEVTVDNRTILLTWMHLLCESFELDKSVFPLSVSILDRYLCK 65
Query: 267 MSVVRSKLQLLGTTALFVASIIEVAEEYKMHNET 300
+ LQ +G + + S I + + T
Sbjct: 66 KQGTKKTLQKIGAACVLIGSKIRTVKPMTVSKLT 99
>pdb|1JOW|A Chain A, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|A Chain A, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|A Chain A, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|A Chain A, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 254
Score = 36.2 bits (82), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 19/94 (20%), Positives = 44/94 (46%), Gaps = 1/94 (1%)
Query: 208 LKCERRIRPKANYMRK-QNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAINYVDRFLSL 266
LK + PK + + Q ++ + R++L+ W+ + E +++ L+++ +DR+L
Sbjct: 27 LKLRELLLPKFTSLWEIQTEVTVDNRTILLTWMHLLCESFELDKSVFPLSVSILDRYLCK 86
Query: 267 MSVVRSKLQLLGTTALFVASIIEVAEEYKMHNET 300
+ LQ +G + + S I + + T
Sbjct: 87 KQGTKKTLQKIGAACVLIGSKIRTVKPMTVSKLT 120
>pdb|1G3N|C Chain C, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|G Chain G, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 257
Score = 33.5 bits (75), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 28/99 (28%), Positives = 50/99 (50%), Gaps = 6/99 (6%)
Query: 275 QLLGTTALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 334
+LLGT + V +EY + + LA+N +DR L + V + Q G+ L VAS
Sbjct: 52 KLLGTW------MFSVCQEYNLEPNVVALALNLLDRLLLIKQVSKEHFQKTGSACLLVAS 105
Query: 335 KYEEIYPPEVNEFVYITDDTYTKKQLLKMETLILKVLNF 373
K + P + Y D++++++L+ E +L+ L +
Sbjct: 106 KLRSLTPISTSSLCYAAADSFSRQELIDQEKELLEKLAW 144
Score = 33.1 bits (74), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 27/87 (31%), Positives = 44/87 (50%), Gaps = 1/87 (1%)
Query: 201 DDIYQYLLKCERR-IRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNETLHLAINY 259
D I+ +L+ E R + + + Q + S MR +L W+ V +EY + + LA+N
Sbjct: 19 DRIFYNILEIEPRFLTSDSVFGTFQQSLTSHMRKLLGTWMFSVCQEYNLEPNVVALALNL 78
Query: 260 VDRFLSLMSVVRSKLQLLGTTALFVAS 286
+DR L + V + Q G+ L VAS
Sbjct: 79 LDRLLLIKQVSKEHFQKTGSACLLVAS 105
>pdb|1F5Q|B Chain B, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|D Chain D, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
Length = 252
Score = 32.0 bits (71), Expect = 0.92, Method: Compositional matrix adjust.
Identities = 23/94 (24%), Positives = 37/94 (39%), Gaps = 4/94 (4%)
Query: 193 LINADDYRDDIYQYLLKCERRIRPKANYMRKQNDINSEMRSVLVDWLIEVAEEYKMHNET 252
L+N +D R IY + ER + + S+ R VL W+ V ++ + N
Sbjct: 14 LLNEEDCRQMIY----RSEREHDARMVGVNVDQHFTSQYRKVLTTWMFCVCKDLRQDNNV 69
Query: 253 LHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 286
LA+ +D + R Q AL +A
Sbjct: 70 FPLAVALLDELFLSTRIDRENYQSTAAVALHIAG 103
>pdb|1C9B|A Chain A, Crystal Structure Of A Human Tbp Core Domain-Human Tfiib
Core Domain Complex Bound To An Extended, Modified
Adenoviral Major Late Promoter (Admlp)
pdb|1C9B|E Chain E, Crystal Structure Of A Human Tbp Core Domain-Human Tfiib
Core Domain Complex Bound To An Extended, Modified
Adenoviral Major Late Promoter (Admlp)
pdb|1C9B|I Chain I, Crystal Structure Of A Human Tbp Core Domain-Human Tfiib
Core Domain Complex Bound To An Extended, Modified
Adenoviral Major Late Promoter (Admlp)
pdb|1C9B|M Chain M, Crystal Structure Of A Human Tbp Core Domain-Human Tfiib
Core Domain Complex Bound To An Extended, Modified
Adenoviral Major Late Promoter (Admlp)
pdb|1C9B|Q Chain Q, Crystal Structure Of A Human Tbp Core Domain-Human Tfiib
Core Domain Complex Bound To An Extended, Modified
Adenoviral Major Late Promoter (Admlp)
Length = 207
Score = 30.4 bits (67), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 40/170 (23%), Positives = 73/170 (42%), Gaps = 20/170 (11%)
Query: 292 EEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLG-------TTALFVASKYEEIYPPEV 344
+E + ++L N VDR +L V + L G + L++A + E + P
Sbjct: 10 KEITTMADRINLPRNIVDRTNNLFKQVYEQKSLKGRANDAIASACLYIACRQEGV-PRTF 68
Query: 345 NEFVYITDDTYTKKQLLKMETLILKVLNFDLNIPTVHSFI---C-HITVSGHLDQSVLYL 400
E ++ +KK++ + LILK L +++ T F+ C ++ + + + ++
Sbjct: 69 KEICAVS--RISKKEIGRCFKLILKALETSVDLITTGDFMSRFCSNLCLPKQVQMAATHI 126
Query: 401 AQYLSELALVSGDPFLQFLPSLIACSAIALARYCLDYKEAWPSSLADITG 450
A+ EL LV G P +A +AI +A K + DI G
Sbjct: 127 ARKAVELDLVPGRS-----PISVAAAAIYMASQASAEKRTQ-KEIGDIAG 170
>pdb|2PHG|A Chain A, Model For Vp16 Binding To Tfiib
Length = 206
Score = 30.4 bits (67), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 40/170 (23%), Positives = 73/170 (42%), Gaps = 20/170 (11%)
Query: 292 EEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLG-------TTALFVASKYEEIYPPEV 344
+E + ++L N VDR +L V + L G + L++A + E + P
Sbjct: 9 KEITTMADRINLPRNIVDRTNNLFKQVYEQKSLKGRANDAIASACLYIACRQEGV-PRTF 67
Query: 345 NEFVYITDDTYTKKQLLKMETLILKVLNFDLNIPTVHSFI---C-HITVSGHLDQSVLYL 400
E ++ +KK++ + LILK L +++ T F+ C ++ + + + ++
Sbjct: 68 KEICAVS--RISKKEIGRCFKLILKALETSVDLITTGDFMSRFCSNLCLPKQVQMAATHI 125
Query: 401 AQYLSELALVSGDPFLQFLPSLIACSAIALARYCLDYKEAWPSSLADITG 450
A+ EL LV G P +A +AI +A K + DI G
Sbjct: 126 ARKAVELDLVPGRS-----PISVAAAAIYMASQASAEKRTQ-KEIGDIAG 169
>pdb|1Z90|A Chain A, X-Ray Structure Of Gene Product From Arabidopsis Thaliana
At3g03250, A Putative Udp-Glucose Pyrophosphorylase
pdb|1Z90|B Chain B, X-Ray Structure Of Gene Product From Arabidopsis Thaliana
At3g03250, A Putative Udp-Glucose Pyrophosphorylase
pdb|2Q4J|A Chain A, Ensemble Refinement Of The Protein Crystal Structure Of
Gene Product From Arabidopsis Thaliana At3g03250, A
Putative Udp-Glucose Pyrophosphorylase
pdb|2Q4J|B Chain B, Ensemble Refinement Of The Protein Crystal Structure Of
Gene Product From Arabidopsis Thaliana At3g03250, A
Putative Udp-Glucose Pyrophosphorylase
Length = 469
Score = 30.4 bits (67), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 19/66 (28%), Positives = 32/66 (48%), Gaps = 7/66 (10%)
Query: 433 YCLDYKEAWPSSLADITGHSLDSLTECVKCLHEVHRKGEAASQKAAYNKYKL----NLWK 488
YC+ E P +LAD+ G +L S V+ L E ++ + K+K+ NLW
Sbjct: 243 YCM---EVTPKTLADVKGGTLISYEGKVQLLEIAQVPDEHVNEFKSIEKFKIFNTNNLWV 299
Query: 489 NVSTVE 494
N+ ++
Sbjct: 300 NLKAIK 305
>pdb|1TFB|A Chain A, Nmr Studies Of Human General Transcription Factor Tfiib:
Dynamics And Interaction With Vp16 Activation Domain, 20
Structures
Length = 208
Score = 30.4 bits (67), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 40/170 (23%), Positives = 73/170 (42%), Gaps = 20/170 (11%)
Query: 292 EEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLG-------TTALFVASKYEEIYPPEV 344
+E + ++L N VDR +L V + L G + L++A + E + P
Sbjct: 11 KEITTMADRINLPRNIVDRTNNLFKQVYEQKSLKGRANDAIASACLYIACRQEGV-PRTF 69
Query: 345 NEFVYITDDTYTKKQLLKMETLILKVLNFDLNIPTVHSFI---C-HITVSGHLDQSVLYL 400
E ++ +KK++ + LILK L +++ T F+ C ++ + + + ++
Sbjct: 70 KEICAVS--RISKKEIGRCFKLILKALETSVDLITTGDFMSRFCSNLCLPKQVQMAATHI 127
Query: 401 AQYLSELALVSGDPFLQFLPSLIACSAIALARYCLDYKEAWPSSLADITG 450
A+ EL LV G P +A +AI +A K + DI G
Sbjct: 128 ARKAVELDLVPGRS-----PISVAAAAIYMASQASAEKRTQ-KEIGDIAG 171
>pdb|2ICX|A Chain A, Crystal Structure Of A Putative Udp-Glucose
Pyrophosphorylase From Arabidopsis Thaliana With Bound
Utp
pdb|2ICX|B Chain B, Crystal Structure Of A Putative Udp-Glucose
Pyrophosphorylase From Arabidopsis Thaliana With Bound
Utp
pdb|2ICY|A Chain A, Crystal Structure Of A Putative Udp-Glucose
Pyrophosphorylase From Arabidopsis Thaliana With Bound
Udp- Glucose
pdb|2ICY|B Chain B, Crystal Structure Of A Putative Udp-Glucose
Pyrophosphorylase From Arabidopsis Thaliana With Bound
Udp- Glucose
Length = 469
Score = 30.0 bits (66), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 19/66 (28%), Positives = 32/66 (48%), Gaps = 7/66 (10%)
Query: 433 YCLDYKEAWPSSLADITGHSLDSLTECVKCLHEVHRKGEAASQKAAYNKYKL----NLWK 488
YC+ E P +LAD+ G +L S V+ L E ++ + K+K+ NLW
Sbjct: 243 YCM---EVTPKTLADVKGGTLISYEGKVQLLEIAQVPDEHVNEFKSIEKFKIFNTNNLWV 299
Query: 489 NVSTVE 494
N+ ++
Sbjct: 300 NLKAIK 305
>pdb|3LQZ|B Chain B, Crystal Structure Of Hla-dp2
Length = 212
Score = 28.5 bits (62), Expect = 8.5, Method: Compositional matrix adjust.
Identities = 20/86 (23%), Positives = 41/86 (47%), Gaps = 5/86 (5%)
Query: 110 DDSTDEVTDKEEKHHDDKEYGNEENEVFDEVAMLPQAFCKAKVWKDEEEPMSLEKSILSP 169
D E E D+EY N + ++ +E +P C+ + PM+L++ +
Sbjct: 62 DSDVGEFRAVTELGRPDEEYWNSQKDILEEERAVPDRMCRHNY--ELGGPMTLQRRVQP- 118
Query: 170 MSVDLSQTEKGTPTRNVEDMVCMLIN 195
V++S ++KG P ++ +VC + +
Sbjct: 119 -RVNVSPSKKG-PLQHHNLLVCHVTD 142
>pdb|1VOL|A Chain A, Tfiib (Human Core Domain)TBP (A.THALIANA)TATA ELEMENT
Ternary Complex
Length = 204
Score = 28.5 bits (62), Expect = 9.5, Method: Compositional matrix adjust.
Identities = 39/170 (22%), Positives = 72/170 (42%), Gaps = 20/170 (11%)
Query: 292 EEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLG-------TTALFVASKYEEIYPPEV 344
+E + ++L N VDR +L + L G + L++A + E + P
Sbjct: 7 KEITTMADRINLPRNKVDRTNNLFRQAYEQKSLKGRANDAIASACLYIACRQEGV-PRTF 65
Query: 345 NEFVYITDDTYTKKQLLKMETLILKVLNFDLNIPTVHSFI---C-HITVSGHLDQSVLYL 400
E ++ +KK++ + LILK L +++ T F+ C ++ + + + ++
Sbjct: 66 KEICAVS--RISKKEIGRCFKLILKALETSVDLITTGDFMSRFCSNLCLPKQVQMAATHI 123
Query: 401 AQYLSELALVSGDPFLQFLPSLIACSAIALARYCLDYKEAWPSSLADITG 450
A+ EL LV G P +A +AI +A K + DI G
Sbjct: 124 ARKAVELDLVPGRS-----PISVAAAAIYMASQASAEKRTQ-KEIGDIAG 167
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.318 0.131 0.376
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 13,268,794
Number of Sequences: 62578
Number of extensions: 504516
Number of successful extensions: 1179
Number of sequences better than 100.0: 50
Number of HSP's better than 100.0 without gapping: 33
Number of HSP's successfully gapped in prelim test: 17
Number of HSP's that attempted gapping in prelim test: 1070
Number of HSP's gapped (non-prelim): 84
length of query: 498
length of database: 14,973,337
effective HSP length: 103
effective length of query: 395
effective length of database: 8,527,803
effective search space: 3368482185
effective search space used: 3368482185
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 53 (25.0 bits)